<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>465-SACUBITRIL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="SACUBITRIL" rxcui="1656328">
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ALISKIREN" rxcui="325646">
<ATC code="C09XA02" />
<ATC code="C09XA52" />
<ATC code="C09DX02" />
</DRUG>
</DRUG2>
<DESCRIPTION>With diabetic patients or those with renal insufficiency, increase of the undesirable effects such as hypotension, hyperkaliemia</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>465-SACUBITRIL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="SACUBITRIL" rxcui="1656328">
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACE INHIBITORS)" code="C09AA" /></DRUG2>
<DESCRIPTION>Increase of the risk of angioedema</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
